ANDA 208833, held by Amneal Pharms. Celecoxib.
As of Nov 15, 2026, ANDA 208833 (Celecoxib), held by Amneal Pharms, was first approved by FDA on May 31, 2018, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 31, 2018 | Original application | Approved | None posted |
| Jan 10, 2023 | Supplement 5Labeling · Standard review | Approved | None posted |
| Jan 10, 2023 | Supplement 6Labeling · Standard review | Approved | None posted |
| Oct 1, 2019 | Supplement 2Labeling · Standard review | Approved | None posted |
| Apr 2, 2019 | Supplement 1Labeling · Standard review | Approved | None posted |
| May 31, 2018 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters